Create Alert
Watchlist

Concord Drugs

₹0.00
0.00 (0.00%) 1D
NSE
1D
1W
1M
3M
6M
1Y
3Y
5Y
All

Performance

Open
0.00
Prev. Close
0.00
Volume
NA
Total traded value
NA
Upper Circuit
NA
Lower Circuit
NA

Fundamentals

Market Cap₹61Cr
ROE0.99%
P/E Ratio(TTM)178.85
EPS(TTM)0.34
P/B Ratio1.78
Dividend Yield0.00%
Industry P/E35.91
Book Value34.11
Debt to Equity0.50
Face Value10
Understand Fundamentals

Financials

*All values are in Rs. Cr
No Graph Data To Display
Quarterly
Yearly

About Concord Drugs

Concord Drugs Limited is an India-based pharmaceutical company. The Company is engaged in manufacturing of licensed drugs based on the formulations approved. The Company offers finished pharmaceutical formulations, such as injectables (small volume parenteral, dry powders), tissue bio-adhesive, tablets, capsules, liquid orals (syrup & suspension) and dry syrups (powder). The Company also provides ready-to-fill pellets and multiple unit pellets system (MUPS). Its pellets are categorized as gastrointestinal drug pellets, cardiovascular drug pellets, respiratory drug pellets, anti-obesity drug pellets, anti-depressant drug pellets, central nervous system drug pellets, urological drug pellets, anti-microbial, anti-infective and adjuvant drugs pellets, taste mask drug pellets/powder, nutrition and food supplement drug pellets, anti-cholesterol drug pellets. The Company also provides Iso Amyl 2-Cyano Acrylate, which is a bio-adhesive product.;
Parent OrganisationConcord Drugs Limited
Managing DirectorMr. Seelam Reddy
BSE Symbol538965

Shareholding Pattern

Jun '24
Sep '24
Dec '24
Mar '25
Jun '25
Promoters
54.39%
Retail And Others
45.61%

Similar Stocks

COMPANY
52 WEEK
MARKET PRICE
P/E Ratio
Cohance Lifesciences
NA
(0.00%)
154.58
Wockhardt
NA
(0.00%)
-2395.14
Emcure Pharmaceuticals
NA
(0.00%)
38.03
JB Chemicals & Pharmaceuticals
NA
(0.00%)
39.09